Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $74.7900 (0.15%) ($74.7700 - $75.7300) on Mon. Feb. 25, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.42% (three month average) | RSI | 66 | Latest Price | $74.7900(0.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.4% a day on average for past five trading days. | Weekly Trend | BAX advances 1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(56%) SPLV(52%) XLP(51%) VYM(50%) DIA(48%) | Factors Impacting BAX price | BAX will decline at least -0.71% in a week (0% probabilities). TLT(-19%) XHB(-10%) IFRA(-9%) VXX(-8%) VIXM(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.71% (StdDev 1.42%) | Hourly BBV | 0 () | Intraday Trend | -0.2% | | | |
|
5 Day Moving Average | $74.22(0.77%) | 10 Day Moving Average | $73.45(1.82%) | 20 Day Moving Average | $72.55(3.09%) | To recent high | 0% | To recent low | 21.7% | Market Cap | $38.157b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |